Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00001318 |
Recruitment Status :
Completed
First Posted : December 10, 2002
Last Update Posted : March 4, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Healthy Mycobacterium Infections, Atypical | Drug: interferon gamma | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 60 participants |
Primary Purpose: | Treatment |
Official Title: | Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma |
Study Start Date : | August 1992 |
Study Completion Date : | November 2000 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Demonstrated non-tuberculous mycobacterial infection, either disseminated or pulmonary.
Received medical treatment for at least 3 months without improvement.
Preserved renal, hepatic and hematologic function.
Negative pregnancy urine and effective contraceptive.
Age range greater than 5.
No secondary immunodeficiency such as HIV or malignancy.
Not currently receiving cytotoxic therapy within the past 3 months.
Not pregnant or lactating.
No seizure disorders.
No known symptomatic cardiac disease.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00001318
United States, Maryland | |
National Institute of Allergy and Infectious Diseases (NIAID) | |
Bethesda, Maryland, United States, 20892 |
ClinicalTrials.gov Identifier: | NCT00001318 |
Other Study ID Numbers: |
920255 92-I-0255 |
First Posted: | December 10, 2002 Key Record Dates |
Last Update Posted: | March 4, 2008 |
Last Verified: | August 1999 |
Immune Adjuvant Phagocytes Non-tuberculous Mycobacterial Infection |
Infection Communicable Diseases Mycobacterium Infections Mycobacterium Infections, Nontuberculous Actinomycetales Infections Gram-Positive Bacterial Infections |
Bacterial Infections Interferons Interferon-gamma Antineoplastic Agents Antiviral Agents Anti-Infective Agents |